chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine administered after temperature excursion; This spontaneous case was reported by a health care professional and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered after temperature excursion) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered after temperature excursion). On 02-Apr-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered after temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Swollen, red and warm to touch at injection site lasting 72 hours post vaccination. Fever, chills, body aches fatigue lasting 48 hours post injection. After 48 hours and other symptoms went away, extreme fatigue and headache set in and lasted 48 hours.  All symptoms were treated with ibuprofen, tylenol and rest.
I received my second Moderna shot on 4/9/2021. I was sick for about 36 hours and it went away. No big deal. On 4/12 I got my period. I haven?t had a period in 3 years because of my birth control. I had really bad cramping and lots of clots. It lasted about 5 days and was gone. On 4/30 I got another period. Same lots of clotting and bad cramps. That went away after about 5-6 days.  I went to the dr on 4/13 and told her about it which she ignored and said it could be anything. She will run labs but won?t check estrogen levels since I?m on birth control. I go for labs on Monday 4/17.  Well on 4/15, which is the day I am writing this I am again on my period. This isn?t normal. As well as the pains that I am constantly feeling in what feels like my tubes or something. I also know I am not the only person this has happened to. The shots have just became available for teens and I have a 14, 12 and 6 year. All girls. And I am all for the shot however this makes me question if it won?t affect my daughters and how it will affect them if it?s doing this to me.  I am hesitant to give it to them and I wasn?t before.
Information has been received from a registered nurse concerning a 14 year old female who on 17-SEP-2007 was vaccinated with the first dose of GARDASIL vaccine 0.5 ml, IM, on 24-SEP-2008 was vaccinated with second dose of GARDASIL vaccine (lot no. 660618/0572X) 0.5 ml, IM. Concomitant therapy included MENACTRA and FLUMIST. On 24-SEP-2008. 5 minutes after vaccination, the patient passed out and fell to the floor hitting the head. The nurse also reported that the patient "had what looked like a little seizure", the patient was hypotensive. The patient was transferred to the emergency room. The head computed axial tomography performed was negative (head normal). The patient was not admitted in the hospital. The patient recovered and was discharged home. The emergency room diagnosis was syncope. Additional information has been requested.
Dizziness; little bit of headache; little bit of fever; may be one degree; Blurry vision; Imbalance; some wobbling on my feet; Palpitations; I am afraid.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 80-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 27Oct2023 as dose 1, single (Batch/Lot number: unknown) at the age of 80 years for covid-19 immunisation. The patient's relevant medical history included: "Parkinsonism" (unspecified if ongoing), notes: I have a diagnosis of Parkinsonism. I take Carbidopa, Levodopa. Concomitant medication(s) included: LEVODOPA, CARBIDOPA taken for parkinsonism, start date: Oct2021. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete, unknown manufacturer), for COVID-19 Immunization. The following information was reported: VISION BLURRED (non-serious) with onset 28Oct2023, outcome "unknown", described as "Blurry vision"; DIZZINESS (non-serious) with onset 28Oct2023, outcome "unknown"; FEAR (non-serious) with onset 28Oct2023, outcome "unknown", described as "I am afraid."; BALANCE DISORDER (non-serious) with onset 28Oct2023, outcome "unknown", described as "Imbalance; some wobbling on my feet"; PALPITATIONS (non-serious) with onset 28Oct2023, outcome "unknown"; PYREXIA (non-serious) with onset 28Oct2023, outcome "unknown", described as "little bit of fever; may be one degree"; HEADACHE (non-serious) with onset 28Oct2023, outcome "unknown", described as "little bit of headache".  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
patient states a few days after immunization she had joint pain and arm weakness that lasted a couple to a few months. it is currently in pretty good shape with only occasional joint ache in her arm when she exercises. she has not had any issues in about 3 weeks.
FLU LIKE SYMPTOMS:  CHILLS, BODY ACHES, HEAD ACHE, STOMACH PROBLEMS, DIARREA  LASTED 3-4 DAYS.  TOOK OTC FOR DIARREA - TYLENOL FOR BODY DISCOMFORT.  SLEPT FOR MOST OF THESE DAYS .
Patient called this morning saying she woke up with hives on her face and itchy eyes after receiving the vaccine yesterday.
CHEMICAL INTOLERANCE; SUDDEN HIGH LEVELS OF AUTOANTIBODIES; SEVERE PAIN; SEVERE INFLAMMATION; FOOD INTOLERANCE; This spontaneous report received from a patient via a company representative via social media concerned a patient of unspecified age, sex, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient was previously received with covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin, and batch number were not reported, expiry: UNKNOWN) dose was not reported, 1 total, start therapy date was not reported for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s. (Dose number in series 1). The patient additionally received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin, and batch number were not reported, expiry: UNKNOWN) dose was not reported, 1 total, start therapy date was not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced chemical intolerance, sudden high levels of autoantibodies, severe pain, severe inflammation, and food intolerance (Dose number in series 2). Laboratory data (dates unspecified) included: Autoantibody test High levels. It was reported as "So you are now going to study the very condition that your Covid vaccines have caused me and many others?! Seriously? I filed a VAERS report, which has been filed with the CDC and FDA, but these reported adverse events go nowhere!!! There is currently no help or studies being done for/on those of us who are having sudden high levels of autoantibodies triggering severe pain and inflammation, food intolerance, chemical intolerance, since being vaccinated and boosted with your Covid Vaccine. Apparently, you discovered your Covid vaccine triggers autoantibodies, then quit the mass manufacturing of it, and now you are going to finds the answer/treatment for the condition you have caused in so many from your vaccine? I sure hope an investigation occurs into J and J Covid Vaccine Adverse Events!" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chemical intolerance, sudden high levels of autoantibodies, severe pain, severe inflammation and food intolerance was not reported. This report was non-serious.
In a retrospective chart review that was conducted in 2 HIV primary care clinics, Patient 7, is an HIV positive patient, at least 18 years of age, with documented history of HBV vaccination administration prior to November 2017, and negative for both HBsAg and anti-HBs after previous HBV-vaccination. Baseline laboratories included HIV RNA 504 copies/mL, CD 4 count 241 cells/uL, CD 4 15%, negative for anti-HBc and negative HCV co-infection. On an unspecified date, the patient received and completed both doses of HEPLISAV-B vaccine. On an unspecified date, the patient was noted as not having achieved seroprotection. Company comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
I had a lot of chills with a fever and dizziness. Slight congestion and a slight cough with a little runny nose with some nausea. I could not work but I feel like I had a mild case.
Total loss of hearing  in left ear.  Steroids by mouth-13 days Steroids injections in ear -once a week for 3 weeks
This case was reported by a pharmacist via call center representative and described the occurrence of muscle soreness in a 50-year-old female patient who received FLUARIX quadrivalent (batch number 2X5YD, expiry date 30th June 2016). Concurrent medical conditions included anxiety. On 5th September 2015, the patient received FLUARIX quadrivalent (subcutaneous). On 5th September 2015, less than a day after receiving FLUARIX quadrivalent, the patient experienced muscle soreness (serious criteria disability), swelling arm (serious criteria disability) and intramuscular formulation administered by other route. On an unknown date, the patient experienced anxiety aggravated (serious criteria disability), nerve pain (serious criteria disability), digestion impaired (serious criteria disability), joint pain (serious criteria disability) and nausea (serious criteria disability). On an unknown date, the outcome of the muscle soreness and swelling arm were recovered/resolved and the outcome of the anxiety aggravated, nerve pain, digestion impaired, joint pain and nausea were not recovered/not resolved and the outcome of the intramuscular formulation administered by other route was unknown. The reporter considered the muscle soreness, anxiety aggravated, nerve pain, digestion impaired, joint pain, swelling arm and nausea to be possibly related to FLUARIX quadrivalent. Additional details were provided as follows: The patient was a physician's wife. The patient received the vaccine in the left arm, subcutaneously which led to incorrect route of vaccine administration. On 5th September 2015, less than a day after vaccination with FLUARIX quadrivalent, the patient experienced sore muscle and arm swelling. In September 2015, less than a month after vaccination with FLUARIX quadrivalent, the patient experienced increased anxiety, nerve pain, digestive problems, joint pain and nausea. In September 2015, sore muscle and arm swelling had resolved.
Severe chills from nose to the toes. Both feet suffered terribly started at approximately mid nite, ceased approximately 8:30 a.m. Have never ever, been this cold 5 blankets, insulated under garments heating pad did not help. Slight stomach sickness, no fever."
I received both doses of the Pfizer-BioNTech COVID-19 Vaccine in January 2022. Since receiving the vaccination my menstrual cycle has been heavier and longer than normal. Also, I have also experienced what I would describe as frequent heart and or chest pain.   I went to an Emergency Room (ER) for the chest pain on 02/03/2022. The staff performed an EKG and  collected blood. I was told that the EKG and lab work results were all normal. My diagnosis was Chest Wall Pain.    I still experience frequent chest wall pain.
Recieved Pneumovax booster 9/19, arm very swollen next 2 days, now has developed mac-pap rash over deltoid, spreading to axilla & chest.  Not cellulitis.  No systemic Sx.
LIFE DESTROYING PAIN/ CHRONIC PAIN (NEW PAIN); This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced life destroying pain/ chronic pain (new pain). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of life destroying pain or chronic pain/ new pain was not reported. This report was non-serious.
Erythema noted approx 3/4 around upper arm right below deltoid. (deltoid area clear), warm to touch, tender, slight edema. Diagnosed by doctor with cellulitis placed on antibiotic-resolved in 4 days pt reported.
Since I got the vaccine, my left eye bothers me in way that I have a watery, itching , red eye & feeling of sand on it. It bothers me  more at night, it started at the same night of vaccination (1/4/21). Today is 1/7/21 and still bothering me.
Heavy vaginal bleeding that did not stop and required an emergency room visit in February after the second shot. Treated initially with progesterone pills while awaiting GYN appt. GYN advised to put in an IUD after a uterine biopsy.
Information has been received from a 72 year old female consumer with blood pressure high, cholesterol and Oesophageal Reflux acid reflux concerning herself who was vaccinated with a dose of GARDASIL instead of the ZOSTAVAX (Merck) by mistake on 06-Jun-2009. Concomitant therapy included Aspirin, Minerals (unspecified), and Vitamins (unspecified), Centrum silver, Fish oil, Calcium citrate and Citracal D, Prilosec, Felodipine, Lipitor and Micardis. The reporter mentioned that she was not experienced any side effects, but was worried and need to know if she needed to be concerned. Unspecified blood work as performed (results not provided). At the report time the outcome was unknown. Additional information has been requested.
No additional AE/PQC.; Caller reported AE on behalf of a patient who was administered an expired dose of GARDASIL 9 with no prior TEs (POTENCY SUPPORTED). No symptoms reported. Obtained consent to contact HCP. Agency Filed (Case #02468279). No additional AE/PQC.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patients' medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported.   On 07-SEP-2023, the patient was vaccinated with an expired dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection 0.5 milliliter (lot#: U008900 with expiration date of 12-AUG-2023; formulation was confirmed as syringe; strength, route of administration and indication were not provided) (PT: Expired product administered). There was no prior "TEs" (potency supported). No symptoms reported. No additional adverse event (AE)/ Product Quality Complaints (PQC) was reported.
Extreme dizziness upon waking at 5:45 a.m. the day after injection.  Dizziness reduced and gone by 2:00 p.m.
Evening p/receiving vax, pt was seen in ER w/red skin over whole body; temp of 100, inc BP told by ER MD was a probable allergic vax rxn rash & other sx resolved w/o intervention;
Administer the vaccine to and individual under 18; This spontaneous case was reported by a nurse and describes the occurrence of   in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: NNI; Reporter's Comments: This case report concerns a 17-year-old male patient who was administered mRNA-1273 vaccine Lot# unknown (inappropriate age at vaccine administration). There was no associated adverse event reported  for the event of inappropriate age at vaccine administration
Intrauterine growth restriction. Treated with Csection at 37 weeks on 5/10/21 ( original estimated due date was 5/28/21). Birthweight only 4lbs 2oz.
About 9 hours after getting vaccine, during the night I developed chills, shakes, extreme fatigue, later had temporary hallucinations (weird!), the following day I had debilitating fatigue I could hardly get myself out of bed, severe headache, body aches and then slowly got better but Day 3 I got stuffy head and slight shortness of breath (I blamed that on seasonal allergies), but then I developed itchiness over my ENTIRE body. I took Benadryl and itch is subsiding. I hope this is the end of side effects!
Localized urticaria noted right upper arm. The follow up received on 11/17/03 states onset redness.
Information was received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 13-JUN-2016, the patient was vaccinated with an improperly stored dose of VARIVAX lot # L045953 (dose, site, route and expiration date not reported). Concomitant therapy was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
approx 3yrs p/vax pt devel rash on face (8 lesions). 17mar99 pt w/chickenpox at MD office. addl info requested
metallic taste; This is a spontaneous report from a contactable consumer (patient). A 36-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was unknown and expiration date not reported) via an unspecified route of administration on an unspecified date (at the age of 36-years-old) as unknown single dose for COVID-19 immunization. The patient medical history included COVID-19 from an unknown date and unknown if ongoing. The patient had no allergies to medications, food, or other products. The patient concomitant medications were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. On May2021, the patient experienced metallic taste. The patient underwent lab tests and procedures which included: post the vaccination on May2021, the patient had sars-cov-2 test and result was unknown. The patient did not receive treatment for the event. The event was considered as non-serious by the reporter. The outcome of event was not resolved.  Information regarding the lot/batch number has been requested.
Patient with URI symptoms and developed vesicles 1st on head, biggest, then over next 24 hours increased vesicles on head, face, back, abdomen. Started 06/25/2006
Starting about 6 hours after the shot on April 2, 2021 and for approximately 48 hours after symptoms started, I experienced extreme fatigue, chills, sweats, muscle aches, and some dehydration.  A few weeks later, on April 15, 2021 I developed a urinary tract infection, which I was positively diagnosed and treated for on April 17, 2021.  I have only had one other urinary tract infection in my life, and that was more than 15 years ago, so this was quite uncommon.  At the beginning of May 2021, I noticed that four of my fingernails had deep horizontal ridges that have finally just grown out to the edge of the nail tip ~5 months after receiving the vaccine.
Pt. with fever >104 & arthralgias, the night after receiving MMR.
Muscle spasms overnight, vertigo with headache, nausea, body aches, and fever the next day
Information has been received from a nurse for GARDASIL, a pregnancy registry product, concerning a 19 year old female patient with medical history of smoke and might have conceived on NUVARING, plan B who on 31-AUG-2007 was vaccinated IM with 0.5 ml dose of GARDASIL (Lot#661846/1312X) at left deltoid. There was no concomitant medication. On 21-AUG-2009 the patient was vaccinated IM with the second 0.5 ml dose of GARDASIL. On 31-AUG-2009 the patient took a urine home pregnancy test and it was positive. The patient came into the office for a pregnancy visit on 22-SEP-2009. On this visit ultrasound performed and estimated due date would be 05-MAY-2010. The last menstruation period was approximately 31-JUL-2009. The patient was not experiencing any problems, there were no adverse effects report. Follow up information has been received from the nurse who reported that on 20-OCT-2009 the patient called to cancel her appointment. Message stated cancellation due to possible miscarriage or termination of pregnancy. No further information noted. On 19-NOV-2009, the nurse left a message for the patient to call the office. There was no follow up phone calls from patient. The nurse was unable to contact again in April 2010 because the phone number is no longer in service. There was no further information and none was anticipated. Possible miscarriage or termination of pregnancy was considered to be an other important medical event. Additional information is not expected.
Systemic: she just had an anxiety attack-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: She notified me she didn't like needles before administration of the vaccine.  I followed proper procedure to administer the vaccine. She then simply had an anxiety attack, which we provided her with ice packs to cool her down for.  She insisted we called the ambulance. She remained responsive and alert the entire time.  EMS did not need to take her into the hospital because she had calmed down a lot by the time they got here. So this is not due to the vaccine itself or the adminstration of it.
ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN ACUTE RESPIRATORY FAILURE
Myalgia, UrticariaPruritus, adenopathy left axilla; erythem at vaccine site Narrative:
strong pain in the vaccinated site six hours after the vaccination; This is a spontaneous report from a non-contactable consumer. An adult patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (reported as 610, CCYYMM) (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced strong pain in the vaccinated site six hours after the vaccination with the outcome of unknown. The patient also received the second dose of BNT162B2 on an unspecified date in Jan2021 (Batch/Lot number was not reported) for COVID-19 immunisation.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The pt developed a 6cm red, warm and tender area around the site of the vaccinia vaccination; treated with 5 days of Levaquin 500mg.
Patient reported dizziness.  Examined patient, states she did not eat breakfast nor water.  Patient had some chicken and rice for lunch.  Gave patient  water and patient rested on bed in Nurses Room at School for 10 minutes.     Patient stands after resting and denies dizziness but c/o dizziness with sitting.   Patient is left in stable condition with school nurse.